Ischemic preconditioning and infarct mass: The effect of hypercholesterolemia and endothelial dysfunction

Clinical and Experimental Hypertension

Volumn 22, Issue 2, 2000, Pages 165-179

  Jung, O ^a   Jung, W ^a   Malinski, T ^b   Wiemer, G ^a   Schoelkens, B A ^a   Linz, W ^a  

^a SANOFI   (France)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Hypercholesterolemia; Ischemic preconditioning; Myocardial infarction; Rabbits

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; COMPLEX FORMATION; CONDITIONING; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HYPERCHOLESTEROLEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; METABOLIC REGULATION; NONHUMAN; RABBIT; RISK BENEFIT ANALYSIS; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA, THORACIC; ARTERIOSCLEROSIS; CALCIMYCIN; CHOLESTEROL; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HYPERCHOLESTEROLEMIA; IONOPHORES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; POLYETHYLENE GLYCOLS; POTASSIUM CHLORIDE; RABBITS; SUPEROXIDE DISMUTASE; VASODILATION;

EID: 0034055877     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-100100070     Document Type: Article

References (37)

1. Vane JR, Änggard EE, Botting RM: Regulatory functions of the vascular endothelium.N Engl J Med 1990;323:27-36.
2. Lüscher TF: Endothelial dysfunction in atherosclerosis. J Myocard Ischemia 1995;7 [Suppl 1]:15-20.
3. Levine GN, Keaney JF, Vita JA: Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-521.
4. Creager MA, Gallagher SJ, Girerd XJ, Colemean SM, Dzau VJ, Cooke JP: L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-1253.
5. Szilvassy Z, Ferdinandy P, Szilvassy J, Nagy I, Karcsu S, Lonovics J, Dux L, Koltai M: The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolemia. J Mol Cell Cardiol 1995;27:2559-269.
6. Becker RHA, Wiemer G, Linz W: Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol 1991;18 (Suppl 2):S110-S115.
7. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH: Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 1993;91:1453-1458.
8. Linz W, Albus U, Crause P, Jung W, Weichert A, Schölkens BA, Scholz W: Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin and Exper Hypertension 1998;20(7):733-749.
9. Hartman JG, Kurc GM, Hullinger TG, Wall TM: Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat. J Pharmacol Exp Ther 1994;270: 1071-1078.
10. Birnbaum Y, Hale SL, Kloner RA: Differences in reperfusion length following 30 min of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. J Mol Cell Cardiol 1997;29:657-666.
11. Miki T, Swafford AN, Cohen MV, Downey JM: Second window of protection in conscious rabbits: real or artifactual. J Mol Cell Cardiol 1998;30:A74 [abstract]
12. März W, Sieckmeier R, Scharnagl H, Seiffert UB, Gross W: Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins. Clin Chem 1993;39(1): 2276-2281.
13. Malinski T, Taha Z: Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 1992;358;676-678.
14. Wiemer G, Linz W, Hatrik S, Schölkens BA, Malinski T: Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats. Hypertension 1997;30:1183-1190.
15. Parratt JR and Vegh A: Endothelial cells, nitric oxide and ischemic preconditioning. Basic Res Cardiol 1996;91:27-30.
16. Ferdinandy P, Szilvassy Z, Baxter GF: Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci 1998;19:223-229.
17. Bolli R, Manchikalapudi S, Tang X-L, Takano H, Qiu Y, Guo Y, Zhang Q, Jadoon AK: The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 1997;81:1094-1107.
18. Bolli R, Dawn B, Tang X-L, Qiu Y, Ping P, Xuan Y-T, Jones WK, Takano H, Guo Y, Zhang J:The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 1998;93:325-338.
19. Ferdinandy P, Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, Szentgyörgyi R, Nagy I, Koltai M, Dux L: Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol 1997;29: 3321-3333.
20. Ferdinandy P, Csonka C, Csont T, Szilvassy Z, Dux L: Rapid pacing-induced preconditioning is recaptured by farnesol treatment in hearts of cholesterol-fed rats: role of polyprenyl derivatives and nitric oxide. Mol Cell Biochem 1998;186:27-34.
21. Le Grand B, Vie B, Faure P, Degryse A-D, Mouillard P, John GW: Increased resistance to ischemic injury in the isolated perfused atherosclerotic heart of the cholesterol-fed rabbit. Cardiovasc Res 1995;30:689-696.
22. Hoshida S, Nishda M, Yamashita N, Igarashi J, Hori M, Kamada T, Kuzuya T: Amelioration of severity of myocardial injury by a nitric donor in rabbits fed a cholesterol rich diet. J Am Coll Cardiol 1996;27:902-909.
23. Hoshida S, Yamashita N, Kawahara K, Kuzuya T, Hori M: Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of athersclerosis. Circulation 1999;99:434-440.
24. Woditsch I, Schrör K: Reduced endothelium-dependent relaxation at enhanced NO release in hearts of hypercholersterolaemic rabbits. Br J Pharmacol 1994;111:1035-1040.
25. Pritchard KA Jr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS, Stememan MB: Native low-density lipoprotein increases endothelial cell nitric oxide synthase gneration of superoxide anion. Circ Res 1995;77:510-518.
26. Quyyumil AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon III RO: Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 1997;29(2):308-317.
27. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA: Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47(1):25-49.
28. Linz W, Wiemer G, Schölkens BA: Beneficial effects of bradykinin on myocardial energy metabolism and infarct size. Am J Cardiol 1997;80(3A):118A-123A.
29. Schaper W, Görge G, Winkler B, Schaper J: The collateral circulation of the heart. Prog Cardiovasc Dis 1988;31:57-77.
30. Reimer KA, Jennings RB: Ischemic preconditioning: a brief review. Basic Res Cardiol 1996;91:1-4.
31. Cohen MV, Downey JM: Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. Annu Rev Med 1996;47:21-29.
32. Fatehi-Hassanabad Z, Furman BL, Parratt JR: Endothelium and ischaemic preconditioning in rat isolated perfused hearts. J Physiol 1996;494P:112P-113P.
33. Schulz R, Post H, Vahlhaus C, Heusch G: Ischemic preconditioning in pigs: A graded phenomenon its relation to adenosine and bradykinin. Circulation 1998;98:1022-1029.
34. Du ZY, Woodman OL: The effect of hypercholesterolemia and atherosclerosis on α -adrenoceptor-mediated vasoconstriction in conscious rabbits and rabbit aorta. Eur J Pharmacol 1991;11:149-156.
35. 1-adrenergic contractile responses in hypercholesterolemic rabbit common carotid arteries. J Cardiovasc Pharmacol 1993;22:58-64.
36. 1 -receptor expression. Am J Physiol 1997;272:H2701-H2707.
37. Kabayashi Y, Miyazaki S, Itoh A, Daikoku S, Morii I, Matsumoto T, Goto Y, Nonogi H: Previous angina reduces in-hospital dearth in patients with acute myocardial infarction. Am J Cardiol 1998;81:117-122.